CFDE Data Portal | Search CFL1P1

	Label	Description
	CFL1P1 associations Collection (Entity type)	Associations for CFL1P1_associations
	CFL1P1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	CFL1P1 Gene (Entity type)	ENSG00000290782 - cofilin 1 pseudogene 1
	GSE135514 dasatinib 8 v 9 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE209698 calcitriol D 2 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE153354 TCF19 knockout CAL-27 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE172016 paclitaxel 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE126651 PRMT5 MTAP inhibition 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE100148 EZH2 inhibition 4 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE135514 dasatinib 8 v 6 human up Gene Set (Entity type)	A Gene Set from LINCS

CFL1P1 associations

Associations for CFL1P1_associations

CFL1P1 associations.tsv

A file from IDG as part of the Harmonizome project

CFL1P1

ENSG00000290782 - cofilin 1 pseudogene 1

GSE135514 dasatinib 8 v 9 human up

A Gene Set from LINCS

GSE209698 calcitriol D 2 v 1 human up

A Gene Set from LINCS

GSE153354 TCF19 knockout CAL-27 0 v 1 human dn

A Gene Set from LINCS

GSE172016 paclitaxel 2 v 1 human dn

A Gene Set from LINCS

GSE126651 PRMT5 MTAP inhibition 1 v 2 human up

A Gene Set from LINCS

GSE100148 EZH2 inhibition 4 v 7 human dn

A Gene Set from LINCS

GSE135514 dasatinib 8 v 6 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.